Clinical Trial Update: A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating sitagliptin in 30 patients with type 2 diabetes mellitus, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (Januvia) (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-11-07